High Treatment Success Rates When Switching to Once Daily Nevirapine Containing Antiretroviral Therapy

INTRODUCTION: Two recent studies have highlighted low rates of virological response to once daily nevirapine containing combination antiretroviral therapy (CART) in treatment naïve HIV-1 infected subjects. AIM: We assessed factors associated with treatment responses in a cohort of HIV-1 infected, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Benzie, Andrew, Marett, Brett, Mackie, Nicola E, Winston, Alan
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627512/
https://www.ncbi.nlm.nih.gov/pubmed/19274065
http://dx.doi.org/10.2174/1874613600802010089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627512/
https://www.ncbi.nlm.nih.gov/pubmed/19274065
http://dx.doi.org/10.2174/1874613600802010089

Ejemplares similares